Weilei Hu

825 total citations
11 papers, 650 citations indexed

About

Weilei Hu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weilei Hu has authored 11 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weilei Hu's work include Cancer Immunotherapy and Biomarkers (4 papers), Extracellular vesicles in disease (3 papers) and Ferroptosis and cancer prognosis (3 papers). Weilei Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Extracellular vesicles in disease (3 papers) and Ferroptosis and cancer prognosis (3 papers). Weilei Hu collaborates with scholars based in China, United States and India. Weilei Hu's co-authors include Guosheng Wang, Yibing Xu, Meihua Sui, Dongsheng Huang, Xiao‐Fang Yu, Yihan Yao, Xin Shou, Tingting Ye, Ashim K. Datta and Yian Wang and has published in prestigious journals such as Frontiers in Immunology, Molecular Cancer and Cancers.

In The Last Decade

Weilei Hu

11 papers receiving 640 citations

Peers

Weilei Hu
Peter Chockley United States
Dahlia M. Besmer United States
Paytsar Topchyan United States
Kathryn J. Farrand New Zealand
Peter Chockley United States
Weilei Hu
Citations per year, relative to Weilei Hu Weilei Hu (= 1×) peers Peter Chockley

Countries citing papers authored by Weilei Hu

Since Specialization
Citations

This map shows the geographic impact of Weilei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilei Hu more than expected).

Fields of papers citing papers by Weilei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilei Hu. The network helps show where Weilei Hu may publish in the future.

Co-authorship network of co-authors of Weilei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Weilei Hu. A scholar is included among the top collaborators of Weilei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilei Hu. Weilei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hu, Weilei, Guosheng Wang, Yian Wang, Matthew J. Riese, & Ming You. (2020). Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade. iScience. 23(10). 101580–101580. 28 indexed citations
2.
Hu, Weilei, et al.. (2020). Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Frontiers in Genetics. 11. 580299–580299. 11 indexed citations
3.
Hu, Weilei, Guosheng Wang, Yundi Chen, et al.. (2020). Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma. Aging. 12(16). 16514–16538. 11 indexed citations
4.
Hu, Weilei, Guosheng Wang, Lonny Yarmus, & Yuan Wan. (2020). Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression. Cancers. 12(9). 2496–2496. 13 indexed citations
5.
Wang, Guosheng, et al.. (2019). Emerging roles and therapeutic value of exosomes in cancer metastasis. Molecular Cancer. 18(1). 53–53. 120 indexed citations
6.
Hu, Weilei, Guosheng Wang, Dongsheng Huang, Meihua Sui, & Yibing Xu. (2019). Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. Frontiers in Immunology. 10. 1205–1205. 294 indexed citations
7.
Wang, Guosheng, et al.. (2019). Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy. Cancers. 11(10). 1560–1560. 110 indexed citations
8.
Hu, Weilei, et al.. (2019). NNMT Regulates Cancer Immunity and Is a Potential Prognostic Biomarker in Gastric and Colorectal Cancers. SSRN Electronic Journal. 1 indexed citations
9.
Shou, Xin, Yong Li, Weilei Hu, et al.. (2018). Six‐gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation. Molecular Oncology. 13(4). 781–791. 15 indexed citations
10.
Lin, Qi, et al.. (2016). Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review. World Journal of Surgical Oncology. 14(1). 159–159. 13 indexed citations
11.
Datta, Ashim K., et al.. (1992). Mathematical Modeling of Batch Heating of Liquids in a Microwave Cavity. Journal of Microwave Power and Electromagnetic Energy. 27(1). 38–48. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026